Tiamulin (Thiamutilin): Pleuromutilin Antibiotic & Anti-Inflammatory Agent for Veterinary Use

Executive Summary: Tiamulin (Thiamutilin, SKU: BA1083) is a semi-synthetic pleuromutilin antibiotic used in veterinary medicine for pigs and poultry, with proven efficacy against Mycoplasma gallisepticum and Actinobacillus pleuropneumoniae (Sun et al. 2017). Its antibacterial mechanism is mediated by binding to the 50S ribosomal subunit, targeting 23S rRNA nucleotides A2058, A2059, G2505, and U2506, thereby inhibiting protein synthesis. Tiamulin also acts as an anti-inflammatory agent by modulating TNF-α-mediated pathways, including NF-κB, MAPK, and JAK/STAT3. The product is available from APExBIO and has established residue limits for safe veterinary use. Quantitative dosing, pharmacokinetic benchmarks, and application protocols are detailed for both in vitro and in vivo research (APExBIO BA1083).

Biological Rationale

Tiamulin (Thiamutilin) is a derivative of pleuromutilin, originally produced by the fungi Pleurotus mutiliz or Clitopilus (Sun et al. 2017). It is classified as a semi-synthetic pleuromutilin antibiotic, uniquely positioned for veterinary applications. Its main indications include infectious disease control in pigs and poultry, with a focus on pathogens such as Mycoplasma gallisepticum, Actinobacillus pleuropneumoniae, and certain Gram-positive bacteria. Unlike other antibiotic classes, pleuromutilins exhibit minimal cross-resistance due to their distinct ribosomal binding mechanism (Sun et al. 2017). Tiamulin is also investigated for anti-inflammatory effects in translational research, notably in models of TNF-α-mediated inflammation. Its use is further supported by established maximum residue limits (MRLs) to ensure food safety. For a focused overview on its mechanism and anti-inflammatory potential, see this mechanistic summary, which this article expands with updated dosing and residue data.

Mechanism of Action of Tiamulin (Thiamutilin)

Tiamulin acts by binding to the peptidyl transferase center of the 50S bacterial ribosomal subunit. It specifically interacts with 23S rRNA nucleotides A2058, A2059, G2505, and U2506 (APExBIO). This interaction blocks the formation of peptide bonds, directly inhibiting bacterial protein synthesis. The unique binding site differentiates pleuromutilins from other antibiotic classes, resulting in rare cross-resistance (Sun et al. 2017). In addition, tiamulin modulates key inflammatory signaling pathways. It inhibits TNF-α-mediated activation of NF-κB, MAPK, and JAK/STAT3, reducing the expression of pro-inflammatory cytokines in cellular assays (tolrestatsupply.com). This dual action underpins its value as both an antibacterial and an anti-inflammatory research tool.

Evidence & Benchmarks

• Tiamulin exhibits minimum inhibitory concentrations (MICs) as low as 0.03 μg/mL against Mycoplasma gallisepticum strain S6 under standardized broth conditions (APExBIO).
• In vivo dosing in poultry (intramuscular) ranges from 5–80 mg/kg, and in pigs from 10–20 mg/kg, with oral administration effective at 20 mg/kg for targeted pathogens (Sun et al. 2017).
• For M. gallisepticum infection, recommended treatment is 45 mg/kg/day for three days (oral), achieving a steady-state serum peak >8.8 μg/mL and an AUC_24h/MIC ≥ 382.58 h (Sun et al. 2017).
• Veterinary MRLs are 100 μg/kg in muscle and 500 μg/kg in liver, as established by regulatory agencies (Sun et al. 2017).
• Tiamulin is soluble in DMSO (≥50.5 mg/mL) and ethanol (≥59.9 mg/mL), but insoluble in water (APExBIO).
• In vitro cell studies use 10–200 μM working concentrations; solutions should be prepared fresh as long-term storage is not recommended (aee788.com).
• Topical 5% tiamulin cream has demonstrated efficacy in alleviating psoriasis-like dermatitis in research models (APExBIO).

Applications, Limits & Misconceptions

Tiamulin (Thiamutilin) is widely used for the treatment and prevention of infectious diseases in livestock, especially in pigs and poultry. It is effective against Mycoplasma spp., Brachyspira hyodysenteriae (swine dysentery), and Actinobacillus pleuropneumoniae (enzootic pneumonia) (Sun et al. 2017). Tiamulin’s anti-inflammatory properties are under investigation for translational research, including skin inflammation models. Its application as a growth promoter in livestock has been reported, though regulatory limitations apply in some regions.

For advanced protocols and troubleshooting in laboratory use, see this workflow guide; this article extends it with updated residue and pharmacokinetic benchmarks.

Common Pitfalls or Misconceptions

• Tiamulin is not active against all Gram-negative bacteria; its spectrum is limited primarily to Gram-positive and select atypical pathogens (Sun et al. 2017).
• Water is not a suitable solvent for tiamulin; use DMSO or ethanol for stock solutions (APExBIO).
• Long-term storage of tiamulin solutions leads to degradation; prepare fresh solutions before use (aee788.com).
• MRLs must be observed strictly; exceeding residue limits in edible tissues poses regulatory and food safety risks (Sun et al. 2017).
• Not all observed anti-inflammatory effects in animal models are directly translatable to humans; further research is needed.

Workflow Integration & Parameters

For in vitro studies, tiamulin is used at 10–200 μM, dissolved in DMSO or ethanol. Solutions should be prepared immediately before use due to instability over time. In vivo dosing for poultry is 5–80 mg/kg (intramuscular) or 45 mg/kg/day (oral) for three days; for pigs, 10–20 mg/kg (intramuscular) and 20 mg/kg (oral) are typical. Efficacy is monitored by achieving serum concentrations above 8.8 μg/mL and maintaining AUC_24h/MIC ≥ 382.58 h. Tiamulin’s pharmacokinetics have been extensively profiled in swine, chickens, and other farm animals (Sun et al. 2017). For a comparison of cell-based workflows, see this procedural article, which this review updates with new solubility and handling parameters.

Product is supplied as an oil (C₂₈H₄₇NO₄S, MW: 493.74). Store at -20°C. Do not freeze-thaw repeatedly. For further experimental workflows and troubleshooting, see this translational review, which this article extends with current regulatory and anti-inflammatory context.

Conclusion & Outlook

Tiamulin (Thiamutilin) remains a cornerstone pleuromutilin antibiotic and anti-inflammatory agent for veterinary and research use. Its dual mechanism ensures robust control of veterinary pathogens and enables investigation of inflammatory signaling. Proper dosing, solution handling, and regulatory adherence (MRLs) are critical for safety and efficacy. APExBIO's BA1083 formulation provides a reliable resource for both laboratory and field applications (Tiamulin for veterinary use). Ongoing research will clarify its role in translational anti-inflammatory therapy and expand its relevance beyond current veterinary domains.